Stockreport

Seneca down 24% on capital raise, warrant exercises [Seeking Alpha]

Seneca Biopharma, Inc.  (SNCA) 
PDF Nano cap Seneca Biopharma (SNCA-23.8%direct offeringThe warrant transactions, which generated ~$3.53M in gross proceeds, represented a26% dilution [Read more]